Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Bonavida

Showing results (121-130 of 192) with videos related to

Pageof 20
Sort By:
Advances in Cancer Research|August 26, 2004
Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosisGolaun Odabaei, Devasis Chatterjee, Ali R Jazirehi, et al.
Molecular Cancer Therapeutics|November 18, 2003
Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosisAli R Jazirehi, Xiao-Hu Gan, Sven De Vos, et al.
Oncogene|August 17, 2005
Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosisMario I Vega, Sara Huerta-Yepez, Ali R Jazirehi, et al.
Cytokine & Growth Factor Reviews|January 20, 2026
TGF-β-YY1 signaling as a key driver of immune evasion in pancreatic cancer: Therapeutic implicationsMai P Ho, Megan Jung, William Ung, et al.
Current Opinion in Hematology|June 10, 2008
NF-kappaB in the pathogenesis and treatment of multiple myelomaZhi-Wei Li, Haiming Chen, Richard A Campbell, et al.
Cancer Research|December 17, 2010
Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interactionAli R Jazirehi, Stavroula Baritaki, Richard C Koya, et al.
International Journal of Oncology|April 2, 2011
The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosisStavroula Baritaki, Loredana Militello, Graziella Malaponte, et al.
Leukemia & Lymphoma|December 8, 2010
A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cellsMario I Vega, Stavroula Baritaki, Sara Huerta-Yepez, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 AxisKatie Lin, Stavroula Baritaki, Silvia Vivarelli, et al.
International Journal of Oncology|April 8, 2010
Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosisEriko Suzuki, Tracy R Daniels, Gustavo Helguera, et al.
Pageof 20

Showing results (121-130 of 192) with videos related to

Sort By:
Pageof 20
Advances in Cancer Research|August 26, 2004
Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosisGolaun Odabaei, Devasis Chatterjee, Ali R Jazirehi, et al.
Molecular Cancer Therapeutics|November 18, 2003
Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosisAli R Jazirehi, Xiao-Hu Gan, Sven De Vos, et al.
Oncogene|August 17, 2005
Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosisMario I Vega, Sara Huerta-Yepez, Ali R Jazirehi, et al.
Cytokine & Growth Factor Reviews|January 20, 2026
TGF-β-YY1 signaling as a key driver of immune evasion in pancreatic cancer: Therapeutic implicationsMai P Ho, Megan Jung, William Ung, et al.
Current Opinion in Hematology|June 10, 2008
NF-kappaB in the pathogenesis and treatment of multiple myelomaZhi-Wei Li, Haiming Chen, Richard A Campbell, et al.
Cancer Research|December 17, 2010
Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interactionAli R Jazirehi, Stavroula Baritaki, Richard C Koya, et al.
International Journal of Oncology|April 2, 2011
The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosisStavroula Baritaki, Loredana Militello, Graziella Malaponte, et al.
Leukemia & Lymphoma|December 8, 2010
A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cellsMario I Vega, Stavroula Baritaki, Sara Huerta-Yepez, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 AxisKatie Lin, Stavroula Baritaki, Silvia Vivarelli, et al.
International Journal of Oncology|April 8, 2010
Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosisEriko Suzuki, Tracy R Daniels, Gustavo Helguera, et al.
Pageof 20